Results 61 to 70 of about 1,121 (159)

A Phase I Trial of the ABCB1 Inhibitor, Oral Valspodar, in Combination With Paclitaxel in Patients With Advanced Solid Tumors. [PDF]

Am J Clin Oncol, 2023
Fracasso PM, Fisher GA, Goodner SA, Beumer JH, Egorin MJ, Fears CL, Wildi JD, Jones GJ, Pearce TE, Sikic BI.   +9 more
europepmc   +1 more source

Interaction of Cyclosporin C with Dy³⁺ Ions in Acetonitrile and in Complex with Dodecylphosphocholine Micelles Determined by NMR Spectroscopy. [PDF]

Int J Mol Sci
Tarasov AS, Minnullina GA, Efimov SV, Kobchikova PP, Khodov IA, Klochkov VV.   +5 more
europepmc   +1 more source

Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2. [PDF]

Cell Rep, 2021
Dittmar M, Lee JS, Whig K, Segrist E, Li M, Kamalia B, Castellana L, Ayyanathan K, Cardenas-Diaz FL, Morrisey EE, Truitt R, Yang W, Jurado K, Samby K, Ramage H, Schultz DC, Cherry S.   +16 more
europepmc   +1 more source

Cyclosporine Toxicity [PDF]

American Journal of Kidney Diseases, 2000
openaire   +2 more sources

Broad-Spectrum Antiviral Activity of Cyclophilin Inhibitors Against Coronaviruses: A Systematic Review. [PDF]

Int J Mol Sci
Elhabyan A, Khan MUS, Elhabyan A, Abukhatwa R, Uzair H, Jimenez C, Elhabyan A, Chan YL, Shabana B.   +8 more
europepmc   +1 more source

Risk factors associated with cytomegalovirus reactivation in patients receiving immunosuppressive therapy for rheumatic diseases: a retrospective study. [PDF]

Sci Rep, 2022
Shimada T, Higashida-Konishi M, Izumi K, Hama S, Oshige T, Oshima H, Okano Y.   +6 more
europepmc   +1 more source

Overlooked Complications and Opportunities in the Development of Drugs Based upon Macrobicyclic Peptides: The "Homeomorphic Switch". [PDF]

J Am Chem Soc
Smith IJ, Popovic SM, Gladysz JA.
europepmc   +1 more source

Biosynthesis of Antituberculosis Antibiotic Capreomycin Involves a <i>trans</i>-Iterative Adenylation Domain within the Nonribosomal Peptide Synthetase Machinery. [PDF]

Org Lett
Lai YT, Peng CY, Liao HT, Hsiao PY, Hsieh CK, Luo YR, Huang SC, Wang YL, Ma T, Chen YR, Kuo YM, Lin YC, Chu J, Chang CY.   +13 more
europepmc   +1 more source

Mapping the inhibition landscape of P-glycoprotein via conformational ensemble docking. [PDF]

Sci Rep
Elbahnsi A, Dragomirescu CD, Palumbo N, Agachi BV, Declèves X, Cisternino S, Isvoran A, Miteva MA.   +7 more
europepmc   +1 more source

Exploratory Study of Sex Differences in P-Glycoprotein Function at the Blood-Brain Barrier. [PDF]

Clin Transl Sci
Salvi de Souza G, Liu W, Mossel P, Somsen JF, Bartels AL, Furini CRG, Lammertsma AA, Tsoumpas C, Luurtsema G.   +8 more
europepmc   +1 more source